Introduction Semaglutide Has emerged as a groundbreaking treatment option for those struggling with type 2 diabetes, obesity, and cardiovascular risk. As part of the GLP-1 receptor agonist class, Semaglutide mimics the actions of a naturally occurring hormone in the body, glucagon-like peptide-1 (GLP-1), which plays a vital role in regulating https://alexisbhknr.sharebyblog.com/31368885/semaglutide-a-breakthrough-in-managing-diabetes-obesity-and-cardiovascular-health